Related Experiment Video
Updated: Aug 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role
Victoria Senior1, Theresa M Marteau, John Weinman
1Psychology and Genetics Research Group, Guy's Medical School, King's College London, Guy's Campus, London, SE1 9RT, UK. v.senior@surrey.ac.uk
Insights
High adherence to cholesterol-lowering medication is reported by familial hypercholesterolaemia (FH) patients, but predictors like age and cardiovascular history influence adherence. Interventions focusing on routine building may improve medication adherence.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Health Psychology
Background:
- Familial hypercholesterolaemia (FH) is a genetic condition leading to high cholesterol.
- Adherence to cholesterol-lowering medication is crucial for managing cardiovascular risk in FH patients.
Purpose of the Study:
- To describe medication adherence levels in adult patients with FH.
- To identify predictors of adherence to cholesterol-lowering medication in this population.
Main Methods:
- A descriptive questionnaire study was conducted with 336 adult FH patients.
- Data collected included self-reported medication adherence, anxiety, depression, and perceptions of heart disease.
Main Results:
- Most participants reported some non-adherence, though overall adherence was high.
- Older age, no formal qualifications, cardiovascular disease history, and lower cholesterol levels predicted higher adherence.
- Perceptions of lower risk, greater control over FH, and genetic determinants of heart attack were associated with adherence.
Conclusions:
- Both clinical factors and patient perceptions influence cholesterol-lowering medication adherence in FH.
- Interventions promoting medication-taking routines may be more effective than those altering patient perceptions.
Background:
The objectives of this study are to describe levels of adherence to cholesterol-lowering medication and to identify predictors of adherence in patients with familial hypercholesterolaemia (FH).
Design:
Descriptive questionnaire study.
Methods:
336 adults patients with FH attending one of five outpatient lipid clinics in South East England underwent a clinical assessment by a nurse and completed a questionnaire. The questionnaire assessed self-reported adherence to cholesterol-lowering medication, anxiety, depression, and patient perceptions of heart disease.
Results:
Overall, participants reported high levels of medication adherence, although 63% reported some level of non-adherence. Total medication adherence (never deviating from the regimen) was more likely to be reported by older participants, those with no formal educational qualifications, those with a personal history of cardiovascular disease, those with a lower total cholesterol level, and those with a greater difference between untreated cholesterol levels and current cholesterol levels. The illness perceptions associated with reported total adherence were lower perceived risk of raised cholesterol, perceiving greater control over FH, and perceiving genes and cholesterol to be important determinants of a heart attack. Emotional state was not associated with medication adherence. In logistic regression analysis, predictors of total medication adherence were having personal history of cardiovascular disease, having no formal qualifications, and perceiving genes to be important determinants of a heart attack.
Conclusions:
Both clinical factors and patients' illness perceptions were associated with self-reported cholesterol-lowering medication adherence. The association with illness perceptions was small and many of these associations may be a consequence, rather than a cause, of greater adherence. Given this, intervention strategies aimed at helping patients' to establish routines for medication taking may be more effective in increasing adherence than interventions designed to alter perceptions related to taking statins.
Related Concept Videos
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
